These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2821070)

  • 1. Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.
    Schach BG; Yoshitake S; Davie EW
    J Clin Invest; 1987 Oct; 80(4):1023-8. PubMed ID: 2821070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two mutations of the factor IX gene including a donor splice consensus deletion and a point mutation in a Dutch patient with severe hemophilia B.
    Poort SR; Briët E; Bertina RM; Reitsma PH
    Thromb Haemost; 1990 Nov; 64(3):379-84. PubMed ID: 2096489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intragenic deletion of the factor IX gene in a family with hemophilia B.
    Chen SH; Yoshitake S; Chance PF; Bray GL; Thompson AR; Scott CR; Kurachi K
    J Clin Invest; 1985 Dec; 76(6):2161-4. PubMed ID: 3001143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophilia B with inhibitor: molecular analysis of the subtotal deletion of the factor IX gene.
    Hassan HJ; Leonardi A; Guerriero R; Chelucci C; Cianetti L; Ciavarella N; Ranieri P; Pilolli D; Peschle C
    Blood; 1985 Sep; 66(3):728-30. PubMed ID: 2992643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients.
    Matthews RJ; Anson DS; Peake IR; Bloom AL
    J Clin Invest; 1987 Mar; 79(3):746-53. PubMed ID: 3029178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor IX Chongqing: a new mutation in the calcium-binding domain of factor IX resulting in severe hemophilia B.
    Wang NS; Zhang M; Thompson AR; Chen SH
    Thromb Haemost; 1990 Feb; 63(1):24-6. PubMed ID: 2339358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA sequence analysis of three inhibitor-positive hemophilia B patients without gross gene deletion: identification of four novel mutations in factor IX gene.
    Matsushita T; Tanimoto M; Yamamoto K; Sugiura I; Hamaguchi M; Takamatsu J; Kamiya T; Saito H
    J Lab Clin Med; 1990 Oct; 116(4):492-7. PubMed ID: 2212858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B.
    Vidaud M; Chabret C; Gazengel C; Grunebaum L; Cazenave JP; Goossens M
    Blood; 1986 Oct; 68(4):961-3. PubMed ID: 2875754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The putative factor IX gene promoter in hemophilia B Leyden.
    Reitsma PH; Bertina RM; Ploos van Amstel JK; Riemens A; Briët E
    Blood; 1988 Sep; 72(3):1074-6. PubMed ID: 3416069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins.
    Chen SH; Thompson AR; Zhang M; Scott CR
    J Clin Invest; 1989 Jul; 84(1):113-8. PubMed ID: 2472424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX.
    Ludwig M; Sabharwal AK; Brackmann HH; Olek K; Smith KJ; Birktoft JJ; Bajaj SP
    Blood; 1992 Mar; 79(5):1225-32. PubMed ID: 1346975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B.
    Lozier JN; Monroe DM; Stanfield-Oakley S; Lin SW; Smith KJ; Roberts HR; High KA
    Blood; 1990 Mar; 75(5):1097-104. PubMed ID: 2306516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular diagnosis of inherited coagulation disorders--sequence analysis of hemophilia B patients with anti-factor IX antibodies].
    Tanimoto M; Matsushita T; Takamatsu J; Saito H
    Rinsho Byori; 1990 Sep; 38(9):1041-6. PubMed ID: 2232265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
    Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
    Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe haemophilia B due to a 6 kb factor IX gene deletion including exon 4: non-homologous recombination associated with a shortened transcript from whole blood.
    Hsu TC; Nakaya SM; Thompson AR
    Thromb Haemost; 2007 Feb; 97(2):176-80. PubMed ID: 17264943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombination between two 14-bp homologous sequences as the mechanism for gene deletion in factor IX Seattle 1.
    Chen SH; Scott CR
    Am J Hum Genet; 1990 Dec; 47(6):1020-2. PubMed ID: 2239965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency).
    Peake IR; Furlong BL; Bloom AL
    Lancet; 1984 Feb; 1(8371):242-3. PubMed ID: 6142993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis and carrier detection of hemophilia B of Chinese origin.
    Lin SW; Shen MC
    Thromb Haemost; 1993 Mar; 69(3):247-52. PubMed ID: 8470048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method to estimate effects of amino acid substitutions in blood coagulation factor IX from hemophilia B patients.
    Furutani H
    Medinfo; 1995; 8 Pt 2():909. PubMed ID: 8591581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.